EBO.NZ - EBOS Group Limited
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.71
|
Rev Est: $7.5B
Price:
--
--
Market Cap:
4.89B
Volume:
277,706
Avg Volume:
374,546
52 Week Range:
23.26-41.98
Sector:
Healthcare
Industry:
Medical - Distribution
Beta:
0.21
Last Dividend:
$1.23
Exchange:
NZE
Country:
AU
Employees:
5,200
IPO Date:
2000-01-04
EPS (TTM):
1.18
P/E Ratio:
32.54
Revenue (TTM):
13.21B
Total Assets:
7.84B
Total Debt:
1.75B
Cash & Equiv:
198.40M
Rev Growth (5Y):
7.1%
EPS Growth (5Y):
2.2%
FCF Growth (5Y):
13.1%
ROCE:
8.4%
Debt/Equity:
0.59
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-08-26 | $0.56 | $0.71 | -21.4% | $9.9B | $6.6B | +50.8% |
| 2025-02-20 | $0.63 | $0.78 | -20.2% | $3.3B | $6.3B | -47.8% |
| 2024-08-21 | $0.77 | $0.84 | -8.5% | $7.2B | $7.1B | +1.3% |
| 2024-02-21 | $0.76 | $0.82 | -6.9% | $7.1B | $7.0B | +1.1% |
| 2023-08-23 | $0.68 | $0.75 | -8.3% | $6.6B | $6.4B | +2.6% |
| 2023-02-23 | $0.77 | $0.80 | -3.5% | $6.8B | $6.3B | +8.3% |
| 2022-06-30 | $0.58 | $0.63 | -8.7% | $6.4B | $5.6B | +14.2% |
| 2021-12-30 | $0.64 | $0.67 | -3.5% | $5.7B | $5.3B | +7.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.21B | 14.41B | 13.32B | 11.45B | 9.89B | 9.38B | 7.25B | 7.61B | 7.63B | 7.10B | 6.07B | 5.76B |
| Net Income | 231.66M | 296.71M | 275.74M | 216.15M | 199.09M | 173.95M | 144.07M | 149.56M | 132.85M | 127.00M | 105.94M | 92.07M |
| EPS | 1.18 | 1.53 | 1.45 | 1.22 | 1.22 | 1.06 | 0.94 | 0.98 | 0.88 | 0.84 | 0.71 | 0.63 |
| Total Assets | 7.84B | 7.37B | 7.01B | 6.95B | 4.24B | 4.01B | 3.35B | 3.26B | 3.21B | 3.19B | 2.55B | 2.31B |
| Total Debt | 1.75B | 1.80B | 1.40B | 1.83B | 730.98M | 865.87M | 556.96M | 634.39M | 596.88M | 367.83M | 426.44M | 405.00M |
| Cash & Equivalents | 198.40M | 237.48M | 230.59M | 573.58M | 181.53M | 261.99M | 174.33M | 163.26M | 162.18M | 120.25M | 109.52M | 88.70M |
| Operating Cash Flow | 450.63M | 376.44M | 425.92M | 275.79M | 320.53M | 245.31M | 124.02M | 176.17M | 143.94M | 224.12M | 133.79M | 114.15M |
| Free Cash Flow | 396.38M | 288.18M | 318.89M | 176.41M | 232.14M | 213.97M | 88.24M | 112.83M | 106.35M | 213.00M | 118.35M | 78.84M |
| FCF per Share | 2.02 | 1.50 | 1.67 | 1.00 | 1.42 | 1.32 | 0.58 | 0.74 | 0.70 | 1.41 | 0.79 | 0.54 |
| Book Value | 2.95B | 2.68B | 2.65B | 2.51B | 1.52B | 1.41B | 1.30B | 1.19B | 1.13B | 1.09B | 1.05B | 979.04M |
| Cash & ST Investments | 198.40M | 236.98M | 230.59M | 573.58M | 181.53M | 261.99M | 174.33M | 163.26M | 162.18M | 120.25M | 109.52M | 88.70M |
| ROC Equity | 0.08 | 0.11 | 0.10 | 0.09 | 0.13 | 0.12 | 0.11 | 0.13 | 0.12 | 0.12 | 0.10 | 0.09 |